Trials / Terminated
TerminatedNCT02475525
Oral Nutritional Supplement in Reducing Surgical Site Infections
The Role of an Arginine Enriched Oral Nutritional Supplement in the Prevention of Wound Complication in Patients Undergoing Lower Limb Revascularization
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- University of Limerick · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study aims to evaluate the efficacy of an arginine enriched oral nutritional supplement in the prevention of wound complications in the the wounds of patients post lower limb revascularization.
Detailed description
Surgical incisions are associated with a number of possible complications. The reported incidence of surgical site infections at the groin after vascular procedures is between 3% and 30%. This incidence is up to five times higher than the expected incidence of infection in clean cases. Risk factors for postoperative surgical site infection in patients undergoing vascular surgery may include age, co-morbidities, use of prosthetic grafts and repeat operations. A systematic review in 2011 concluded that arginine supplemented diets among perioperative patients were associated with a reduced rate of surgical infection and reduced overall length of hospital stay. The study aims are to determine if taking an oral nutritional supplement reduces the rate of wound complications post lower limb revascularization.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Arginine enriched oral nutritional supplement | oral nutritional supplement containing arginine |
Timeline
- Start date
- 2015-06-01
- Primary completion
- 2016-12-01
- Completion
- 2017-02-01
- First posted
- 2015-06-18
- Last updated
- 2018-05-04
Locations
1 site across 1 country: Ireland
Source: ClinicalTrials.gov record NCT02475525. Inclusion in this directory is not an endorsement.